Polysialylated CD56 drives immune evasion in clear cell renal cell carcinoma via engagement of the Siglec-7 checkpoint on CD8+ T cells
International Immunopharmacology · 2026
DOI: 10.1016/j.intimp.2026.116302 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2026. Verfasst von Yuli Jian und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The First Affiliated Hospital of Dalian Medical University, Dalian Medical University, Dalian 116011, China; Department of Bio…. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, CD8-Positive T-Lymphocytes, Kidney Neoplasms, Lectins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Dalian Medical University, National Natural Science Foundation of China.
Abstract (Originalsprache)
Immune checkpoint blockade has revolutionized clear cell renal cell carcinoma (ccRCC) treatment, yet therapeutic resistance remains a significant clinical challenge. Aberrant glycosylation contributes to tumor progression and immunotherapy resistance. However, the specific glycans and corresponding immunomodulatory receptors involved in ccRCC remain poorly understood. Here, we identify polysialylated CD56 (PSA-CD56) as a key glycan-mediated immune regulator that drives immunosuppression in ccRCC through engagement of Siglec-7. Elevated PSA-CD56 expression was inversely correlated with CD8+ T cell infiltration and predicted inferior responses to immunotherapy. Genetic ablation of NCAM1 (encoding CD56) in renal epithelial cells suppressed tumor growth and enhanced CD4+ and CD8+ T cell infiltration in vivo. Mechanistically, PSA-CD56, but not its non-polysialylated form, directly bound to Siglec-7 on CD8+ T cells, suppressing the production of IFN-γ and TNF-α and promoting T cell apoptosis. Importantly, blocking the PSA-CD56/Siglec-7 interaction with specific antibodies restored T cell effector functions and triggered apoptosis of ccRCC cells. Our study unveils the PSA-CD56/Siglec-7 axis as a novel glyco-immune checkpoint, which represents a promising target for therapeutic interventions in ccRCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, The First Affiliated Hospital of Dalian Medical University, Dalian Medical University, Dalian 116011, China; Department of Biochemistry and Molecular Biology, Liaoning Provincial Core Lab of Glyco…
- Department of Biochemistry and Molecular Biology, Liaoning Provincial Core Lab of Glycobiology and Glycoengineering, College of Basic Medical Sciences, Dalian Medical University, Dalian 116044, China.
- Department of Urology, Xijing Hospital, Air Force Military Medical University, Xi'an 710032, China. Electronic address: garyzhu1988@hotmail.com.
- Department of Urology, The First Affiliated Hospital of Dalian Medical University, Dalian Medical University, Dalian 116011, China. Electronic address: yangdeyong@dmu.edu.cn.
- Department of Biochemistry and Molecular Biology, Liaoning Provincial Core Lab of Glycobiology and Glycoengineering, College of Basic Medical Sciences, Dalian Medical University, Dalian 116044, China. Electronic address…
Förderung
- Dalian Medical University
- National Natural Science Foundation of China
Zitieren
APA
Jian, Y., Gong, L., Tang, L., Zhang, M., You, S., Li, Z., Wu, M., Wang, S., Zhu, Z., Yang, D., & Wang, S. (2026). Polysialylated CD56 drives immune evasion in clear cell renal cell carcinoma via engagement of the Siglec-7 checkpoint on CD8+ T cells. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2026.116302
Vancouver
Jian Y, Gong L, Tang L, Zhang M, You S, Li Z, et al. Polysialylated CD56 drives immune evasion in clear cell renal cell carcinoma via engagement of the Siglec-7 checkpoint on CD8+ T cells. International Immunopharmacology. 2026. doi:10.1016/j.intimp.2026.116302
BibTeX
@article{Jian2026,
author = {Jian, Yuli and Gong, Li and Tang, Ling and Zhang, Moyuan and You, Shiya and Li, Zhilin and Wu, Mingxin and Wang, Shuang and Zhu, Zheng and Yang, Deyong and Wang, Shujing},
title = {Polysialylated CD56 drives immune evasion in clear cell renal cell carcinoma via engagement of the Siglec-7 checkpoint on CD8+ T cells},
journal = {International Immunopharmacology},
year = {2026},
doi = {10.1016/j.intimp.2026.116302}
}
EUVIMED